Post Profile






IDH and CIC mutations provide prognostic information for grade II and III gliomas

(NRG Oncology) NRG Oncology investigators have identified two biomarkers that are prognostic of overall and progression-free survival for patients with lower-grade gliomas.
read more

share

Related Posts


Smoking Status Seems To Be Most Important Prognostic Factor, Not EGFR Mutation, In Non-Small Cell Lung Cancer

Health : Medical News Today

Recent studies have demonstrated that molecular-targeted agents, such as epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI), may prolong survival of selected patients based on tumor biomarkers. The presence of ...

Intensity modulated pelvic radiation therapy reduces patient reported toxicities

Health : EurekAlert: Health

(NRG Oncology) NRG Oncology investigators report better patient-reported quality of life measures for women who received intensity modulated radiation therapy (IMRT) for their pelvic radiation therapy (RT) than those who received st...

For Patients With Gliomas, Radiopharmaceuticals Used To More Accurately Manage Treatment, Predict Survival

Health : Medical News Today

In the management of gliomas - or tumors that originate in the brain - precise assessment of tumor grade and the proliferative activity of cells plays a major role in determining the most appropriate treatment and predicting overall...

MRI assessment of rectal cancer provides crucial prognostic information to improve survival for patients

Health : Medical News Today

Research published in this month's Journal of Clinical Oncology found that pre-op MRI assessment is crucial in helping to inform a more advanced treatment approach for rectal patients by predicting local recurrence and disease-free ...

Aushon's Multiplex Immunoassay Platform Used To Validate Panel Of Prognostic And Predictive Protein Biomarkers In Recent Phase II And III Studies

Health : Medical News Today

Data was presented at the recent American Society of Clinical Oncology's 2011 Genitourinary Cancers Symposium showing multiple protein biomarkers predictive of clinical benefit and prognostic of disease outcome in patients with adva...

Comments


Copyright © 2016 Regator, LLC